COVID-19 in vulnerable populations, its long-term effect, and the effectiveness of remdesivir

Projects lasting up to 9 months should collect data on the clinical course and outcome of COVID-19 in vulnerable populations, investigate long-term consequences of COVID-19 in patients, or test the safety and effectiveness of remdesivir in treating the disease.

Up to $250,000 USD
Agency or Funder
Foreign participation? (where known)
Date of announcement
Date application deadline